Erectile dysfunction: Multiple treatment options

Data showed that 87.8% of treated patients and 96.1% of patients who completed the study achieved normal 24-hour mean plasma testosterone values (222 to 800 ng/dL) at 90-day follow-up.

“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.

"This study identifies a new target for VTE prevention," writes Kate Gessner, MD, PhD, and Philip Abbosh, MD, PhD.

“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.

The oral TRT study plans to enroll 20 male patients aged 18 to 49 years who meet the American Urological Association’s criteria for hypogonadism and who have not previously used TRT.

The study is set to begin in January 2024.